Financhill
Back

Novo Nordisk A/S 10K Form

Buy
72

NVO
Novo Nordisk A/S

Last Price:
121.46
Seasonality Move:
3.15%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NVO News And Ratings

See the #1 stock for the next 7 days that we like better than NVO

NVO Financial Statistics

Sales & Book Value

Annual Sales: $33.72B
Cash Flow: $-1.06B
Price / Cash Flow: 54.84
Annual Sales: $3.55
Price / Book: 34.98

Profitability

EPS (TTM): 2.70250
Net Income (TTM): $12.15B
Gross Margin: $28.53B
Return on Equity: 92.18%
Return on Assets: 30.15%

Novo Nordisk A/S Earnings Forecast

Key Novo Nordisk A/S Financial Ratios

  • The Gross Profit Margin over the past 40 years for NVO is 84.60%.
  • The Selling, General & Administrative Expenses for NVO have been equal to 26.52% of Gross Profit Margin.
  • The Research & Development expenses have been 13.97% of Revenue.
  • The Interest Expense is 0.65% of Operating Income.
  • The Net Earning history of NVO is 36.03% of Total Revenues.
  • Per Share Earnings over the last 40 years have been positive in 35 years.

Novo Nordisk A/S Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Biotechnology
Sector: Healthcare
Current Symbol: NVO
CUSIP: 670100
Website: novonordisk.com

Debt

Debt-to-Equity Ratio: 0.2
Current Ratio: 0.82
Quick Ratio: 0.62

Price-to-Earnings

Trailing P/E Ratio: 45.87
Forward P/E Ratio: 31.1

NVO Technical Analysis vs Fundamental Analysis

Buy
72
Novo Nordisk A/S (NVO) is a Buy

Is Novo Nordisk A/S a Buy or a Sell?

  • Novo Nordisk A/S stock is rated a Buy
    The current Novo Nordisk A/S [NVO] share price is $124.01. The Score for NVO is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.